Latest Breaking News On - Detlev biniszkiewicz - Page 1 : comparemela.com

Ex-Eisai leader Ivan Cheung to be new NextPoint CEO—Chutes & Ladders

Ex-Eisai leader Ivan Cheung to be new NextPoint CEO—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesMax bayerGeorge daneker jrIvan cheungMonika vnukMadeleine roachShin mukaiZaven kaprielianEmmanuel frenehardNina kotsopoulouMark kirschbaumJames dohertyRoche genentechPhilippe bishop

After Eisai retirement, Ivan Cheung is back to lead Massachusetts biotech

After Eisai retirement, Ivan Cheung is back to lead Massachusetts biotech
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomIvan cheungDetlev biniszkiewiczFormer eisaiNextpoint therapeuticsNorth americanMassachusetts based nextpointSanofi ventures

NextPoint Therapeutics Appoints Tatiana Novobrantseva, PhD, as Chief Scientific Officer

NextPoint Therapeutics Appoints Tatiana Novobrantseva, PhD, as Chief Scientific Officer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Detlev biniszkiewiczFairjourney biologicsKlaus rajewskyTatiana novobrantsevaOncology researchUniversity of cologneHarvard medical schoolAlnylam pharmaceuticalsPoint therapeutics appoints tatiana novobrantsevaChief scientificPoint therapeuticsChief scientific officerChief executive officerVerseau therapeuticsScientific advisory boardsVoro therapeutics

Latest Updates of Viva s Portfolio Companies

/PRNewswire/ Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term.

United statesAl iskandariyahSan diegoSouth san franciscoViva bioinnovatorPrnewswire triumvira immunologicsDetlev biniszkiewiczJohn mummDeka biosciencesHuya bioTriumvira immunologicsGenhouse bioArthrosi therapeutics incStrategic research collaborationTriumvira immunologics incBioshanghai biopharmaceutical industry investment forum

Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact

Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Al iskandariyahUnited statesDeka biosciencesCytovance biologicsViva bioinnovatorJohn mummDetlev biniszkiewiczEcho investment capitalAlexandria venture investmentsAmana investmentsPlains venturesManaging director